SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001640455-22-000042
Filing Date
2022-04-28
Accepted
2022-04-28 16:13:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A jnce04282022defa14a.htm DEFA14A 10764
2 jnce_noticex2022x1a.jpg GRAPHIC 203535
3 jnce_noticex2022x2a.jpg GRAPHIC 117703
  Complete submission text file 0001640455-22-000042.txt   454324
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37998 | Film No.: 22866700
SIC: 2836 Biological Products, (No Diagnostic Substances)